For that reason, in patients with acromegaly secondary to McCune Albright Syndrome, medical treatment is preferred, and somatostatin analogs improve GH and IGF-1 levels in most cases, though IGF-1 normalization is not frequent and additional treatment with pegvisomant is usually needed and effective. This evidence concerns the gene IGF1 and McCune-Albright syndrome.